Novartis Investigative Site

Adana, Saricam 01330

2 studies enrolling now · 5 studies all time

What they study most

Familial Hypercholesterolemia - Heterozygous, Familial Hypercholesterolemia - Homozygous, Heterozygous or Homozygous Familial Hypercholesterolemia, Sickle Cell Disease, Sickle Cell Disease (SCD)

Studies at this site

• Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia — Recruiting now
• Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study — Recruiting now
• Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies — Recruiting now
• Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia — Recruiting now
• Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients — Running, not enrolling